Trial Profile
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary) ; Tobramycin
- Indications Cystic fibrosis; Pseudomonal infections
- Focus Therapeutic Use
- Acronyms TEACH
- 27 Oct 2021 Primary endpoint (relative change in lung function) has not been met as per results published in the Thorax
- 27 Oct 2021 Results published in the Thorax
- 24 Feb 2020 Status changed from active, no longer recruiting to completed.